Welltower Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Welltower Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 165.20 $ to 252.10 $ · Last price: 232.30 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: REIT - Healthcare Facilities
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Welltower Inc WELL | 164.0 | 115.0 | 63.8 | 39.6 | 18.0 | 35.8 | 42.1 |
| Ventas Inc VTR | 42.9 | 164.4 | 24.5 | 40.0 | 13.8 | 18.5 | 32.9 |
| Omega Healthcare Investors Inc OHI | 14.4 | 23.5 | 12.7 | 97.9 | 65.5 | 14.0 | 20.7 |
| Healthpeak Properties Inc DOC | 14.2 | 66.6 | 12.1 | 57.7 | 12.3 | 4.5 | 21.0 |
| American Healthcare REIT, Inc. AHR | 10.7 | 91.9 | 28.6 | 19.3 | 6.4 | 9.2 | 29.2 |
| CareTrust REIT Inc. CTRE | 8.8 | 25.4 | 19.4 | 96.4 | 57.8 | 108.8 | 15.8 |
| Healthcare Realty Trust Incorporated HR | 6.4 | – | 16.1 | 62.0 | 11.5 | -6.9 | 7.8 |
| Sabra Healthcare REIT Inc SBRA | 5.1 | 32.5 | 19.3 | 50.3 | 31.4 | 10.2 | 14.5 |
| National Health Investors Inc NHI | 3.4 | 23.2 | 14.9 | 73.9 | 61.3 | 12.9 | -7.3 |
| Median of companies shown | 10.7 | 49.5 | 19.3 | 57.7 | 18.0 | 12.9 | 20.7 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 4,252 | 1,308 | 1,078 | 2.99 | 1,639 | 14,806 | 28,865 |
| 2017 | 4,299 | 1,108 | 523 | 1.42 | 1,434 | 14,423 | 27,944 |
| 2018 | 4,671 | 1,161 | 805 | 2.15 | 1,584 | 14,632 | 30,342 |
| 2019 | 5,100 | 1,238 | 1,232 | 3.05 | 1,536 | 15,540 | 33,381 |
| 2020 | 4,587 | 727 | 979 | 2.35 | 1,365 | 17,225 | 32,484 |
| 2021 | 4,709 | 763 | 336 | 0.79 | 1,275 | 17,636 | 34,910 |
| 2022 | 5,776 | 746 | 141 | 0.30 | 1,329 | 21,394 | 37,893 |
| 2023 | 6,478 | 940 | 340 | 0.66 | 1,602 | 25,404 | 44,012 |
| 2024 | 7,854 | 1,146 | 952 | 1.56 | 2,256 | 31,956 | 51,044 |
| 2025 | 10,667 | 355 | 937 | 1.38 | 2,882 | 42,130 | 67,303 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.19 | 24.50 | 2,219 | 29.20 | 5.40 | 559 | 545 |
| 2025: Q1 | 0.39 | 79.20 | 2,389 | 30.50 | 10.80 | 599 | 587 |
| 2025: Q2 | 0.45 | 7.20 | 2,516 | 40.40 | 12.00 | 770 | 761 |
| 2025: Q3 | 0.41 | -43.70 | 2,686 | 30.60 | 10.50 | 858 | 852 |
| 2025: Q4 | 0.14 | -28.20 | 3,134 | 41.20 | 3.10 | 654 | 647 |
| 2026: Q1 | 1.00 | 154.30 | 3,306 | 38.40 | 22.00 | 670 | 282 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 1 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.88 | 2.88 – 2.88 | 14,450 | – | 1 |
| 12/31/2027 | 3.18 | 2.95 – 3.45 | 16,765 | 10.4% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 23.1% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $2.66B |
|---|---|
| Market cap | $163.99B |
| Free cash flow in year ten | $21.25B |
| Terminal value as a share of market value | 68.3% |
For comparison: over the past five years free cash flow grew by 16.2% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 22.7%
- More than 10% revenue growth is expected for the coming year 13.3%
- Share count grows by less than 3% a year 13.5%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 62.5%
- Gross margin at 40% or higher and without meaningful erosion 39.2%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 7.1 x EBITDA
- Operating cash flow covers the profits of the last three years 4,511 m
- Return on capital at 15% or higher, or up versus two years ago 0.5%
- Insiders hold at least 10% or are net buyers 0.1%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
5/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 10.8%
- Exp. sales growth 3Y > 5% 25.4%
- EBIT growth 10Y > 5% -13.5%
- Exp. EBIT growth 3Y > 5% 51.9%
- Net debt < 4x EBIT 46.0x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 72.8%
- Return on equity > 15% 2.4%
- ROCE > 15% 0.5%
- Expected return > 10% 54.5%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Gundlach Andrew | Director | Buy | 2,500 | 242.06 | 605,150 |
| Aug 25, 2026 | Gundlach Andrew | Director | Buy | 2,500 | 239.47 | 598,675 |
| Aug 20, 2026 | Lopez Dennis G | Director | Other | 73 | 237.40 | 17,330 |
The company
About the Company
Welltower Inc. ist ein S&P-500-Unternehmen, das im Zentrum der „Silver Economy" steht und sich auf Mietwohnungen für alternde Senioren in den USA, dem Vereinigten Königreich und Kanada konzentriert.
- Employees
- 712
- Headquarters
- Toledo, OH
- Address
- 4500 Dorr Street, 43615-4040 Toledo, United States
- Phone
- 419 247 2800
- Website
- welltower.com
- IPO Date
- 01/02/2001
- ISIN
- US95040Q1040
- Stock Split
- 3:2 on 09/04/1985
Management
| Name | Title | Birth Year |
|---|---|---|
| Shankh S. Mitra | CEO & Director | 1981 |
| Timothy G. McHugh C.F.A. | Co-President & CFO | 1985 |
| Nikhil Chaudhri | Co-President & Chief Investment Officer | 1988 |
| John F. Burkart | Vice Chairman & COO | 1964 |
| Matthew Grant McQueen J.D. | Chief Legal Officer, General Counsel & Corporate Secretary | 1973 |
| Joshua T. Fieweger | Senior VP & Chief Accounting Officer | 1981 |
| Jeff Stott | Chief Technology Officer | – |
| Tucker Joseph | Chief Information Officer | – |
| John Olympitis | Executive VP & Head of Corporate Development | – |
| Pam Byrne | Senior VP & Head of Human Capital | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.